Phospholipase A2, Group XVI (PLA2G16)

[Edit]

HRASLS3; AdPLA; HREV107; HRAS-Like Suppressor 3; Adipose-Specific PLA2; Adipose-specific phospholipase A2; Group XVI phospholipase A1/A2; H-rev 107 protein homolog

Phospholipase A2, Group XVI (PLA2G16)
Secretory phopholipase A2 (PLA2) enzymes cleave an acyl ester bond in the sn-2 position of glycerophospholipids. These extracellular proteins have a high disulfide bond content, low molecular mass (14 kDa), and require mM levels of Ca2+ for catalysis. Lipolysis for the provision of fatty acids (FA) for other organs during times of energy demand occurs uniquely in white adipose tissue (WAT). Recent findings have identified a bona fide TAG hydrolase and the major adipose phospholipase A2, AdPLA. By controlling PGE2 levels, AdPLA dominantly regulates lipolysis in an autocrine/paracrine manner. Moreover, recent findings demonstrate that, surprisingly, increasing lipolysis in adipose tissue does not necessarily increase serum FA levels, which are usually correlated with insulin resistance.

Organism species: Homo sapiens (Human)

CATALOG NO. PRODUCT NAME APPLICATIONS
Proteins n/a Recombinant Phospholipase A2, Group XVI (PLA2G16) Recombinant Protein Customized Service Offer
Antibodies n/a Monoclonal Antibody to Phospholipase A2, Group XVI (PLA2G16) Monoclonal Antibody Customized Service Offer
n/a Polyclonal Antibody to Phospholipase A2, Group XVI (PLA2G16) Polyclonal Antibody Customized Service Offer
Assay Kits n/a CLIA Kit for Phospholipase A2, Group XVI (PLA2G16) CLIA Kit Customized Service Offer
n/a ELISA Kit for Phospholipase A2, Group XVI (PLA2G16) ELISA Kit Customized Service Offer

Organism species: Mus musculus (Mouse)

CATALOG NO. PRODUCT NAME APPLICATIONS
Proteins n/a Recombinant Phospholipase A2, Group XVI (PLA2G16) Recombinant Protein Customized Service Offer
Antibodies n/a Monoclonal Antibody to Phospholipase A2, Group XVI (PLA2G16) Monoclonal Antibody Customized Service Offer
n/a Polyclonal Antibody to Phospholipase A2, Group XVI (PLA2G16) Polyclonal Antibody Customized Service Offer
Assay Kits n/a CLIA Kit for Phospholipase A2, Group XVI (PLA2G16) CLIA Kit Customized Service Offer
n/a ELISA Kit for Phospholipase A2, Group XVI (PLA2G16) ELISA Kit Customized Service Offer

Organism species: Rattus norvegicus (Rat)

CATALOG NO. PRODUCT NAME APPLICATIONS
Proteins n/a Recombinant Phospholipase A2, Group XVI (PLA2G16) Recombinant Protein Customized Service Offer
Antibodies n/a Monoclonal Antibody to Phospholipase A2, Group XVI (PLA2G16) Monoclonal Antibody Customized Service Offer
n/a Polyclonal Antibody to Phospholipase A2, Group XVI (PLA2G16) Polyclonal Antibody Customized Service Offer
Assay Kits n/a CLIA Kit for Phospholipase A2, Group XVI (PLA2G16) CLIA Kit Customized Service Offer
n/a ELISA Kit for Phospholipase A2, Group XVI (PLA2G16) ELISA Kit Customized Service Offer
  1. "Transcriptional and translational downregulation of H-REV107, a class II tumour suppressor gene located on human chromosome 11q11-12."Oncogene 17:1305-1312(1998) [PubMed] [Europe PMC] [Abstract]
  2. "hH-Rev107, a class II tumor suppressor gene, is expressed by post-meiotic testicular germ cells and CIS cells but not by human testicular germ cell tumors."Oncogene 20:5155-5163(2001) [PubMed] [Europe PMC] [Abstract]
  3. "Characterization of the human tumor suppressors TIG3 and HRASLS2 as phospholipid-metabolizing enzymes."Biochim. Biophys. Acta 1791:1114-1124(2009) [PubMed] [Europe PMC] [Abstract]
  4. "Complete sequencing and characterization of 21,243 full-length human cDNAs." Nat. Genet. 36:40-45(2004) [PubMed] [Europe PMC] [Abstract]
  5. "The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC)."Genome Res. 14:2121-2127(2004) [PubMed] [Europe PMC] [Abstract]
  6. "Antigens recognized by autologous antibody in patients with renal-cell carcinoma."Int. J. Cancer 83:456-464(1999) [PubMed] [Europe PMC] [Abstract]
  7. "The class II tumour suppressor gene H-REV107-1 is a target of interferon-regulatory factor-1 and is involved in IFNgamma-induced cell death in human ovarian carcinoma cells."Oncogene 21:2829-2839(2002) [PubMed] [Europe PMC] [Abstract]
  8. "Mechanisms of the HRSL3 tumor suppressor function in ovarian carcinoma cells."J. Cell Sci. 120:1393-1404(2007) [PubMed] [Europe PMC] [Abstract]
  9. "Solution structure of the N-terminal catalytic domain of human H-REV107 -- a novel circular permutated NlpC/P60 domain."FEBS Lett. 584:4222-4226(2010) [PubMed] [Europe PMC] [Abstract]
  10. "Structural basis for the acyltransferase activity of lecithin:retinol acyltransferase-like proteins."J. Biol. Chem. 287:23790-23807(2012) [PubMed] [Europe PMC] [Abstract]
  11. "Structure/Function relationships of adipose phospholipase A2 containing a cys-his-his catalytic triad."J. Biol. Chem. 287:35260-35274(2012) [PubMed] [Europe PMC] [Abstract]